PIN1 and neoplasm: Nonetheless, the use of liposomal formulations to vehicle a potent, but not cell-permeable, PIN1 inhibitor in cancer cells has shown effectiveness in curbing tumor growth in vivo (175), implying that such a strategy could be applied to other inhibitors with scarce pharmacokinetic properties.